Prevention Grant Recipients

We will never have a world without ALS until we can prevent it. That is why we are proud to support investigations like these through our Prevention Grants that could help prevent or delay the onset of ALS in the next 5–7 years.  

2022 Recipients 

Michael Benatar, M.D., Ph.D., University of Miami’s Miller School of Medicine 
Gene-Environment Interactions for Predicting Onset of Clinically Manifest ALS  

Pascal Falter-Braun, Ph.D., Helmholtz Zentrum München
Understanding and Preventing Virus-Triggered ALS  

Stephen Goutman, M.D., University of Michigan
Defining the ALS Exposome in At-Risk Individuals to Guide ALS Prevention Efforts  

Andrew Grierson, Ph.D., University of Sheffield  
Environmental Toxins in ALS: Validation and Repurposing Therapeutics  

Matthew Harms, M.D., Columbia University College of Physicians and Surgeons
PREVENT ALS: A Multi-Site Longitudinal Study of At-Risk ALS Mutation Carriers  

Jeehye Park, Ph.D., The Hospital for Sick Children  
Evaluation of Metabolic Interventions for ALS Prevention


Print Friendly and PDF